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Immunological three-way chat
Previous reports have implicated polymorphonuclear leuko-
cytes (PMNs) in the immune response to Candidas albicans at 
the oral mucosa. Subsequent investigation revealed that mam-
malian Toll-like receptor 4 (TLR4), which serves as a pathogen 
pattern recognition receptor, is essential in the complex cross-
talk among pathogen, immune system, and epithelia. In the 
presence of both C. albicans and PMNs, TLR4 mRNA and pro-
tein expression were upregulated in oral epithelium. This upreg-
ulation was tightly correlated with protection of the epithelium 
from cell damage. Blockade of TLR4 with specific antibodies 
or knockdown of TLR4 using RNAi restored a virulent pheno-
type, supporting the critical role of this receptor in orchestrating 
the potent immune response to microbial infection. Although 
direct contact between PMNs and epithelia is prevented, 
C. albicans appears to stimulate epithelial cell secretion of cyto-
kines, including interleukin-8 and granulocyte–macrophage 
colony-stimulating factor, which then likely recruit PMNs to 
the site of infection and activate a cascade of events via TLR4. 
(J Clin Invest 117:3664–72, 2007)
Tumor cell evasion
Based on evidence that transplant organ recipients treated with 
T-cell immunosuppressive agents have a higher incidence of 
skin cancer, Pivarcsi and colleagues investigated mechanisms 
of tumor immune escape by transformed cells. Human skin 
tumors apparently downregulate expression of the keratino-
cyte-specific homeostatic chemokine CCL27. Activation of 
the Ras oncogene suppressed expression of CCL27 in keratin-
ocytes. Recombinant epidermal growth factor (EGF) similarly 
decreased CCL27 expression, whereas inhibition of the EGF 
receptor with erlotinib, a small-molecule inhibitor, increased 
CCL27 protein expression in vitro and in vivo. This factor, which 
is downstream of Ras signaling, seemingly regulates the expres-
sion of CCL27. In a mouse model, CCL27-neutralizing antibod-
ies enhanced tumor growth via inhibition of leukocytes at the 
tumor site. Thus, these results describe a novel mechanism used 
by tumors to evade immune surveillance and offer new pos-
sibilities for the development of antitumor immunotherapies. 
(Proc Natl Acad Sci USA 104:19055–60, 2007)
Negative effects of inflammation
During tissue repair, inflammatory cells are recruited to wound 
sites in order to defend against potential pathogens; however, 
these players can provoke a fibrotic response and contribute to 
scarring and related pathologies. Microarray studies demon-
strated that osteopontin (OPN) is expressed in wound granula-
tion tissue fibroblasts concurrently with wound inflammation. 
When Mori and colleagues downregulated OPN expression 
using antisense oligodeoxynucleotides in mouse skin wounds, 
the rate and quality of the wound repair were increased. In addi-
tion, downregulation of OPN altered collagen organization and 
decreased neutrophil and macrophage recruitment to wound 
sites. Increased vessel invasion was also noted. OPN, therefore, 
contributes to fibrosis via a variety of mechanisms, including 
stimulating the inflammatory response, altering matrix factors, 
and affecting angiogenesis. These findings illuminate potential 
targets for developing treatment of wounds and fibrosis. (J Exp 
Med 205:43–51, 2008)
Contribution to itch
The common skin disorder primary localized cutaneous amy-
loidosis (PLCA) presents with severe itching, a symptom that 
is not very well understood at the molecular level. The genetic 
locus, but not the affected gene, of this autosomal-dominant 
disease has previously been identified. Genetic mapping and 
subsequent candidate gene sequencing of DNA from a large 
Brazilian family with familial PLCA cases revealed a missense 
mutation in the oncostatin M receptor β (OSMRβ) gene in all 
affected patients. Further analysis of two other families con-
firmed mutations in this gene in affected patients. The mutations 
occurred in the extracellular fibronectin type III–like domains, 
which were previously implicated in receptor function and sig-
naling transduction. Interestingly, stimulation of PLCA-cultured 
keratinocytes with appropriate ligands (OSM or interleukin-31) 
reduced phosphorylation of downstream signaling molecules 
with antiapoptotic effects (pSTATs, pERK, and pAkt). Thus, 
OSMRβ signaling may contribute to increased downstream 
apoptosis and to the itching phenotype in PLCA, although the 
mechanism of action is not yet clear. (Am J Hum Genet 82:73–
80, 2008)
Human fibroblasts made pluripotent
Yamanaka’s group previously generated induced pluripotent 
stem (iPS) cells from mouse somatic cells. This group recently 
described the successful generation of iPS cells from human 
dermal fibroblasts by transduction of the same four transcrip-
tion factors: Oct3/4, Sox2, Klf 4, and c-myc. These cells were 
remarkably similar to human embryonic stem (ES) cells with 
respect to morphology, proliferation, global gene expression 
patterns, epigenetic modification of promoters of ES cell-spe-
cific genes, and growth. Under various differentiation media 
conditions, these human iPS cells differentiated into all three 
germ layers as well as into neural cells and cardiac myocytes. 
Formation of teratomas in immunodeficient mice demonstrated 
the pluripotent nature of these iPS cells as endodermal, meso-
dermal, and ectodermal tissues were identified. These findings 
are particularly promising for the generation of patient-specific 
therapies, as well as for drug discovery and toxicity testing; 
however, further research into the mechanism of induction of 
this pluripotency and into the differences between human iPS 
and human ES cells is essential. (Cell 131:1–12, 2007)
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